Most CD4+ T cells could not recognize cancer cells directly due to a lack of MHCII (Major Histocompatibility complex II) in most solid cancer cells (except melanoma and breast cancer [40]), whereas CD4+ and CD8+ T cells are activated in spleens under immune activation and inflammatory conditions [41]. The gene discussed is CD8A; the disease is breast carcinoma.